Table 3.
Anti-spike antibody status in vaccinated dialysis patients at six months.
| Anti-Spike Negative n = 38 |
Anti-Spike Positive n = 104 |
p-Value | |
|---|---|---|---|
| Age | 64.5 ± 11.4 | 63.5 ± 12.2 | p = 0.67 |
| Male Female |
24 (63%) 14 (37%) |
63 (61%) 41 (39%) |
p = 0.85 |
| HD PD |
31 (82%) 7 (18%) |
84 (81%) 20 (19%) |
p = 1.00 |
| Diabetes | 25 (67%) | 60 (58%) | p = 0.33 |
| Albumin (gr%) | 3.7 ± 0.49 | 3.90 ± 0.38 | p = 0.004 |
| Dialysis vintage (years) | 3.7 ± 3.40 | 4.2 ± 3.55 | p = 0.48 |
| Kt/V HD Kt/V PD |
1.37 ± 0.33 2.20 ± 0.65 |
1.45 ± 0.38 2.36 ± 0.57 |
p = 0.30 p = 0.54 |
| One month anti-spike antibody (AU/mL) median (25–75) |
41.4 (16–86) | 134 (104–178) | p < 0.001 |
| 3-month anti-spike antibody (AU/mL) median (25–75) |
8.8 (7.1–13.4) | 81.5 (45.5–117) | p < 0.001 |
| 6-month anti-spike antibody (AU/mL) median (25–75) |
8.44 (4.3–12.1) | 48.4 (28.4–86.2) | p < 0.001 |
HD—hemodialysis; PD—peritoneal dialysis; Kt/V—dialysis adequacy.